Beth Stavola Archives - Green Market Report

Brenda LougheryJanuary 22, 2021
Beth-pic.jpg?fit=549%2C768&ssl=1

13min6290

Beth Stavola laughs when she recalls the early days of her cannabis career almost a decade ago, landing back in her home state of New Jersey after one of countless trips to her cannabis businesses in Arizona. She lived in a state that had what was widely considered at the time the most restrictive medical cannabis program in the entire country, worked in a state thousands of miles away that had a growing MMJ market and its own risks — and did it all in a country where her entire business was considered criminal. She was blazing new trails as one of the few  women in an exciting new industry — but couldn’t openly share her successes with her children and friends. 

“It was my dream, every time I landed at Newark,” she says now. “I would say ‘it would be great to have an amazing program in New Jersey to see my friends, family and my fellow New Jersey-ians able to reap the many benefits of medical cannabis treatment.” 

Now with New Jersey having approved cannabis for adult (“recreational”) use and expected to see its first retail sales by later this year, Beth Stavola is seeing her dream come true, and then some. In the span of less than a decade, Stavola has gone from a passive investor in Arizona and other states to a true cannabis trailblazer, as the first (and currently only) woman to be awarded a cannabis license in New Jersey. She is currently in court in regards to her abrupt departure from iAnthus (OTC: ITHUF), the troubled management company she joined earlier in 2020 before leaving in August. As a New Jersey court weighs its decision, Stavola looks back at her early days in Arizona and forward at New Jersey adult use and the challenges her home state will face. 

From the Jersey Shore to the Green Rush 

A self-described “proud Jersey Shore mom,” Stavola has built her career on Wall Street as senior vice president of Institutional Equity Sales at Jefferies New York while raising her six children, including twin girls. It was after the birth of her twins that she decided to retire from Wall Street, while keeping an eye out for other opportunities that looked promising. “I can’t lie, I love to work,” she says. “And I wanted something to keep my mind sharp.

At the time Chris Christie was serving as governor of the Garden State, and while New Jersey did have a medical marijuana program, he made little effort to expand access or even work towards destigmatizing the medicine, referring to it as simply a “front” for legalization efforts.

“Back then it was NOT popular in New Jersey or really anywhere on the East Coast. It was thought of as a California thing or a Colorado ‘experiment,’” says Stavola. But then a deal broker brought her an opportunity to invest in medical marijuana in Arizona, and “I decided to jump in with both feet.” 

“My biggest concern back then was discussing this with my children and then how would I be viewed by others. Would I be viewed as the “pot mom” and my daughters would be ostracized because of my new profession?”

In addition to the social risks back home; in Arizona, the risks of working in a federally prohibited industry started to become part of Stavola’s new reality. “These were things that kept me up at night, like the many concerns that the pioneers of this industry had every day, she says.

“Will all of my employees be safe today, given the fact that we can’t deposit any of this cash in the bank?  I slept with a phone in my bed for a very long time, for my children (anyone with teens knows that feeling) but also for my other family out in Arizona — wanting to make sure that everyone was able to lock up the stores safely and return safely from work to their families.  These were the days where individuals were taking real risks in even deciding to take a job in the industry, whether it was being denied a mortgage for their first home or loan for their first car, to the stigma attached for their own children – the same the way I was feeling about protecting my own family.”

An Accidental Activist 

The more involved Stavola became in her cannabis business, she began to see the impact that cannabis medicine was having on the lives of the people she served in Arizona. Veterans and other patients who had been prescribed countless pharmaceuticals (“oxy-everything,” Stavola says) mothers desperate to save their children’s lives — Stavola became more involved in the value of cannabis as medicine. Suddenly, she says, cannabis went from a passive financial investment to the “true passion” of her life. She went on to found Stavola Medical Marijuana Holdings, Health for Life Inc., Melting Point Extracts, GreenMart of Nevada and CBD For Life. By 2017, she had built a multi-million-dollar portfolio, which she sold to a Canadian company later known as MPX Bioceutical and joined the company to run its US operations. It is under a separate WBE entity, MPX New Jersey, that Stavola holds her license to grow, manufacture and sell cannabis that is the subject of the current litigation with iAnthus.   

While Stavola won’t discuss details surrounding her tenure and departure from iAnthus or the NJ lawsuit, she does say that the experience, as well as her early days in Arizona, has further informed her understanding of the industry and some of its continuing issues. 

“I want to focus on women and minority (owned) businesses being able to successfully participate — not just put forth and then wiped out after the big win: all of a sudden you have a staff that’s fabulous –looks like the model of true diversity — and then having it (become) a bunch of white men in suits. The switcheroo.”

“One of the things that I think overall in the industry that needs to be addressed is that people say, “Oh isn’t cannabis so great, so inclusive to women!” And I say, “well sure, if you want to be a pastry chef or run a trim room. But look in the C-suite of a lot of these big companies, and there’s only one female CEO among all of the big MSOs.” 

Looking to the Future of New Jersey Adult Use

In regards to leadership for state cannabis operators, Stavola is confident that New Jersey regulators and leaders are highly motivated to ensure diversity in the new adult use market. With adult use on the near horizon, New Jersey operators will be finding a more competitive cannabis landscape than ever going forward. The adult use bill allows for more licenses to be issued for recreational sales — and Stavola is looking forward to losing her distinction as the only woman license holder in New Jersey cannabis to make way for more women and minority owned businesses to get a piece of the legal cannabis pie.

Moreover, she acknowledges that more licenses are absolutely necessary to meet the demand of the adult use market in a state of 9 million people. “I’ve never been one who’s fearful of competition; I think it’s healthy,” she says.

However, she acknowledges that entry into the adult market must be gradual, and only as long as the medical market’s need can be met. “We can’t as a state be pulling the rug out from medical patients,” she says. Stavola says she has full confidence in the rollout being overseen by Jeff Brown at the NJ Dept of Health. “He’s very thoughtful in the way that he is thinking about rolling this out, and he’ll be front and center.”

On Becoming the “First Lady” of New Jersey Cannabis

Stavola’s cannabis journey came full circle in 2018, when she was awarded one of the current 12 licenses in the state of New Jersey as the only woman owned cannabis business in the state. She says it represents for her the pinnacle of not only her career and accomplishments in the cannabis  industry, but also as a mother.

“It brings tears to my eyes now to even discuss, I made my daughters so proud after all the years of feeling that I had to keep my passion somewhat hidden for their protection, Stavola says. “My daughters were so proud to see their mom lead the charge in this industry in our home state of New Jersey for women!.  Currently MPX NJ is the only women owned cannabis license in the state of New Jersey and I want to be a huge part of leading the charge for women and minority groups to participate in this incredible industry.  I went from shielding my daughters from the stigma and harm that I felt my involvement in the legal cannabis business could create for them to being a role model for these young girls and women looking to become entrepreneurs and BOSSES in this industry.”

 


StaffMarch 6, 2020
Untitled-design-40.png?fit=960%2C640&ssl=1

11min253125

In honor of International Women’s Day, we are releasing our annual “Most Important Women in Weed” list for 2020. This list includes women in the industry that have collectively moved the industry forward with all of their hard work, continuous dedication and effort.

This year we opened up the list for nominations and received almost a thousand nominees. After consideration of each, we have developed what we feel is one of the most inclusive and carefully curated lists of the most accomplished and impressive women in the cannabis industry.

As we could not name them all, we would like to thank and celebrate all of the women who have dedicated their precious time to the advancement of cannabis globally.

It is because of each one of these ladies that this industry remains in the lead above all others as far as female leadership is concerned.

This list is in no special order. Each one of these women provide a great contribution to the cannabis industry in their own unique and badass way.

Thank you to every one of you for all that you do!

The “List”

Dr. Chanda Macias

Yvonne DeLaRosa Green

Mara Gordon

Rosie Mattio

Shawna McGregor

Lori Ferrara

Gaynell Rogers

Stormy Simon

Trista Okel 

Lori Ajax

Amy Dawn Bourlon-Hilterbran

Kim Rivers

Amanda Soens

Dona Frank

Kat King

Sara Payan

Hannah Daphna

Sandra Castaneda

Erin Gore

Wendy Kornberg

Kristin Nevedal

Wendy Turner

Parisa Rad

Brittany Nicholson

Emily Paxhia

Jessica Billingsley 

Gia Moron

Andrea Brooks

Tahira Rehmatullah

Tracey Mason

Lindy Snyder

Jasmine Rose Gunderson

Shannon Hattan

Adelia Carrillo

Karen Petersen

Wanda James

Barbara Blaser

Ophelia Chong

Amanda Ostrowitz

Pamela Nicole Epstein

Melissa Mentele

Jamie Cooper

Sarah Remesch

Jessie Gill

Erica Daniels

Lizzy Jeff

Lelehnia DuBois

Whitney Beatty

Dr. Michele Ross

Manndie Tingler

Chef Lauren Gockley

Kyra Reed

Jamie Evans

Kristin Jordan

Ellie Siegel 

Sara Brittany Somerset

Linda Marsicano

Heidi Groshelle

Amber Senter

Nique Pichette

Jennifer Price

Molly Peckler 

Bonita Money

Susan Hwang

Judy Yee

Julie Chiarello

Leah Heis

Leslie Andrachuk

Terra Carver

Nancy Whiteman

Luna Stower

Karen Paull and Wendy Robbins

Beth Stavola

Alison Gordon

Penny Green

Sara Gullickson

Dr. Lakisha Jenkins

Pamela Hadfield

Jessica Peters

Dr. Rachel Knox and Dr. Jessica Knox

Tiffany Bowden

Mary Jane Gibson

Michelle Janikian

Dr. Uma Dhanabalan

Taylor Blake

AC Braddock

Kerri Accardi

Heather Sobel

Betty Aldworth

Cathy Jordan

Suzanne Sisley

Nina Parks

Eliza Nova Maroney

Selena Xochitl Martinez

Angelika Penuela-Ruiz

Sarah Mitra Payan

Gretchen Gailey

Nikki Lastreto

Ann Lawrence

Sheena Shiravi

Christina Ianuzzi

Kassandra Frederique

Shannon Buyers

Celia Tapp

Kelly Archer

Katie Field

Randi Sether

Shannon Reed

Katrina Yolen

Ngiste Abebe

Brooke Westlake

Courtney Maltais

Katrina Tso

Anne Don0hoe

Alicia Rose Kelley

Dr. Jacqueline Harding, PhD 

Mary Pryor 

Dr. Uma Dhabalan

Olivia Mannix

Heather DeRose

Libby Cooper

Leslie Hoffman

Yvonne Perez Emerson

 

Again, thank you to all of the women who do so much in our industry day in and day out. Your work does not go unnoticed and is deeply appreciated.

Happy International Women’s Day to all women around the world!

Special shout out to our Green Market Report co-founders Debra Borchardt and Cynthia Salarizadeh on this day!


StaffJuly 3, 2019
Elizabeth-Stavola-Chief-Strategy-Officer-and-Director-iAnthus-.jpg?fit=429%2C600&ssl=1

5min1960

Beth Stavola is a leading cannabis entrepreneur. She was formerly the Chief Operating Officer, President of US Operations, and Board Member of MPX Bioceutical Corporation, and is now the Chief Strategy Officer and Director for iAnthus. Beth is also the founder of the top CBD beauty and wellness brand, CBD For Life, a privately-held company that provides customers with the benefits of cannabinoids while avoiding unwanted psychoactive effects. Previously, Beth worked on Wall Street with Jefferies and Company, rising to the position of Senior Vice President. She is actively involved in organizations that promote women in the cannabis industry and in 2014 was named as one of the leading medical cannabis entrepreneurs by Congresswoman Dina Titus, on the floor of the House of Representatives.  In 2017, Cannabis Business Executive named Beth #3 on the “CBE 75 Most Important Women In Cannabis” list.

GMR Executive Spotlight Q&A –

Full birth name: Beth Stavola  

Title: Chief Strategy Officer and Director

Company: iAnthus Capital Holdings

Years at current company: <1 

Education profile:  Beth Stavola holds the esteemed honor of being named as one of the leading medical cannabis expert entrepreneurs on the floor of the House of Representatives in 2014 by Congresswoman Dina Titus. She holds a BS in Finance and Economics from Monmouth University and spent most of her Wall Street career at Jefferies and Company.  

Most successful professional accomplishment before cannabis:   While I structured and closed many deals during my time in finance, being the #1 producer in my department the most times during a ten-year career at Jefferies is the highlight. I think it shows my determination to succeed professionally no matter the industry. A personal investment in medical cannabis lead me on this incredible journey where I am able to combine my passion and experience to help people. Sometimes opportunities happen where you least expect them and working with people who have different perspectives can open your mind to new ways of thinking and growing your business.

Company Mission: In the high growth environment of the U.S cannabis market, an experienced team, access to capital and an ability to grow through acquisition are the three key drivers of a company’s success. iAnthus was founded by entrepreneurs who bring together market leading experience in operations, capital markets and M&A.

Combining these skills, we are building a cannabis company that will seize the opportunities this emerging industry offers.

Company’s most successful achievement:  The transformational Deal with MPX which closed in February 2019 was the first public-to-public U.S. cannabis transaction with an HSR filing to be approved by the Department of Justice. The combined company now has operations in 11 states. 

Has the company raised any capital (yes or no): if so, how much?  

We have raised 360mm CAD to date.

Any plans on raising capital in the future? I’m unable to comment on future plans.

Most important company 5-year goal:  Our biggest goal is to expand our brands into new and diverse markets as they open up in the U.S. and abroad. This will ensure that our customers receive the highest quality products in a timely, efficient and reliable way, as our brands become recognized nationally and internationally under the iAnthus umbrella.

 


Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

By continuing I agree to your Privacy Policy and consent to receive relevant newsletters and other email communications on events, editorial features, and special partner offers from Green Market Report. I can unsubscribe or change my email preferences at any time.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 18 hours

Body and Mind Reports Slumping Sales as New Dispensaries Come Online

@GreenMarketRpt – 19 hours

Planet 13’s Financial Numbers Down Across the Board for 2022, Losses Jump 152%

@GreenMarketRpt – 20 hours

Atai Life Sciences Losses Shrunk in 2022 Amid Restructuring Bid

Back to Top

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

By continuing I agree to your Privacy Policy and consent to receive relevant newsletters and other email communications on events, editorial features, and special partner offers from Green Market Report. I can unsubscribe or change my email preferences at any time.